Three of the CD45-negative samples (M66, M63 and M68) expressed β2m and not the other three components, indicating that the majority of medulloblastomas fail to express MHC class I. The fourth sample (M69) expressed all four components. The gene discussed is PTPRC; the disease is medulloblastoma.